AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 39 filers reported holding AN2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $89,264,824 | +178.3% | 5,551,295 | +47.1% | 1.76% | +189.9% |
Q2 2023 | $32,074,895 | -13.9% | 3,773,517 | 0.0% | 0.61% | -28.1% |
Q1 2023 | $37,244,613 | +3.6% | 3,773,517 | 0.0% | 0.84% | +15.6% |
Q4 2022 | $35,961,617 | -45.2% | 3,773,517 | 0.0% | 0.73% | -47.9% |
Q3 2022 | $65,584,000 | +125.8% | 3,773,517 | +0.7% | 1.40% | +80.5% |
Q2 2022 | $29,050,000 | -47.4% | 3,748,389 | +2.2% | 0.78% | -35.7% |
Q1 2022 | $55,257,000 | – | 3,666,663 | – | 1.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,678,209 | $43,065,600 | 6.34% |
Octagon Capital Advisors LP | 867,575 | $13,950,606 | 2.14% |
RA Capital Management | 5,551,295 | $89,264,824 | 1.76% |
Frazier Life Sciences Management, L.P. | 1,388,889 | $22,333,335 | 1.48% |
Avidity Partners Management LP | 1,089,400 | $17,517,552 | 0.70% |
BVF INC/IL | 1,563,963 | $25,148,525 | 0.68% |
Monashee Investment Management LLC | 99,495 | $1,599,880 | 0.67% |
Nantahala Capital Management | 356,789 | $5,737,167 | 0.49% |
ACUTA CAPITAL PARTNERS, LLC | 13,300 | $213,864 | 0.14% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 905,556 | $14,561,340 | 0.03% |